Localised immune checkpoint therapy for cutaneous head and neck cancer (2024–2026)
- Grant type:
- TRI Leading Innovations through New Collaborations Scheme
- Researchers:
-
-
- Funded by:
- The Trustee for Translational Research Institute Trust
